Cannabis Science Inc (fka CBIS)

[NickDz]

no, they haven't had ample time to enter the market with a product; they're trying to get FDA approval, and simply by having a product related at all to the medecine they are sending for FDA approval on the market disqualifies them from being able to apply for FDA approval; this is why phytiva was spun off in December of last year, to allow it to happen. this is why Dorothy Bray came on board this year, to leverage her connections and because she has an interest in the ongoing success of this company.